Congo to receive 70,000 doses of Ervebo Ebola vaccine which has been effective in past outbreaks
The Democratic Republic of the Congo is set to receive 70,000 doses of an Ebola vaccine that may not be effective against the current strain.
Evidence dossier
Intelligence passport
Measured timeline
- Detected The first matching coverage entered the Archynetys cluster.
- Evidence threshold reached The story had enough independent coverage for an explanatory brief.
- Latest coverage observed Most recent article currently attached to this story cluster.
- Peak measured velocity The recorded velocity reached 5.
Source diversity sample: The Jerusalem Post · World Health Organization (WHO) · Al Jazeera · Reuters · AP News · PBS · NDTV.
How this dossier is built: methodology · AI policy · corrections.
Questions people are asking
What is the Ervebo vaccine?
The Ervebo vaccine is an Ebola vaccine manufactured by Merck. It has been effective in past outbreaks.
Why is the Ervebo vaccine not approved for the current Ebola strain in the DRC?
The WHO has stated that the Ervebo vaccine is not approved for the current strain of Ebola in the DRC. The reason for this is not specified in the coverage.
How many doses of the Ervebo vaccine is the DRC set to receive?
The DRC is set to receive 70,000 doses of the Ervebo vaccine.
🌍 Cross-language spread
This story first appeared in 🇫🇷 French coverage — 6.8 hours before Archynetys detected it in English news.
Detected by matching proper nouns and figures that survive translation. Times reflect when each edition's coverage was first indexed.
What happened
The Democratic Republic of the Congo (DRC) is preparing to receive 70,000 doses of the Ervebo Ebola vaccine. This vaccine has proven effective in past outbreaks. However, the World Health Organization (WHO) has stated that it is not approved for the current strain of Ebola circulating in the country.
The WHO and the Africa Centers for Disease Control and Prevention (Africa CDC) have welcomed the allocation of these vaccines. The Ervebo vaccine is manufactured by Merck. It has been used successfully in previous Ebola outbreaks.
The DRC is currently experiencing a surge in Ebola infections, prompting the urgent need for vaccination. The WHO's statement raises questions about the efficacy of the Ervebo vaccine against the current Ebola strain. The DRC's health authorities will need to address this discrepancy as they implement the vaccination campaign.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 2h ago.
Who reported it (7)
- DRC set to receive 70,000 Ebola vaccines, not approved for current strain, WHO says The Jerusalem Post · 8h ago
- WHO and Africa CDC welcome the allocation of Ebola vaccines to the Democratic Republic of the Congo World Health Organization (WHO) · 8h ago
- DR Congo to receive 70,000 doses of Ervebo vaccine as Ebola infections surge Al Jazeera · 8h ago
- Congo set to receive 70,000 Ervebo vaccines to contain Ebola outbreak, WHO says Reuters · 8h ago
- Congo to receive 70,000 doses of Ervebo Ebola vaccine which has been effective in past outbreaks AP News · 8h ago
- Congo to receive 70,000 doses of Ervebo Ebola vaccine, which was effective in past outbreaks PBS · 10h ago
- Ebola-Hit DR Congo Gets 70,000 Doses Of Ervebo Vaccine: WHO NDTV · 10h ago
Momentum
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Topics
Related trends
Congo’s Ebola outbreak reaches 5,000 cases as it outpaces response efforts at unprecedented speed
The Ebola outbreak in Congo is accelerating faster than response efforts can keep up
A convergence of biological risks
Experts warn of a new wave of biological threats, driven by AI and extremist groups.
Congo: Ebola cases rising at record pace
Ebola is killing one person every 30 minutes in Congo, as cases surge at a record pace
DRC’s fast-growing Ebola outbreak spreads to sixth province
The Ebola virus is rapidly expanding across the Democratic Republic of Congo, reaching a sixth province as international containment efforts struggle to keep pace.
Gaza cancer patients face rising death rate amid Israeli curbs, doctors say
Cancer patients in Gaza face a rising death rate due to Israeli restrictions on medical access.
‘Mismatched’ vaccine being rolled out against Ebola outbreak
Public health agencies are deploying an Ebola vaccine that does not perfectly match the circulating virus strain while preparing new clinical trials.
Open prediction lab
Can you beat the machine?
Pick tomorrow's top trend, then compare your result with Archynetys's self-graded forecast.
📬 The daily trend digest
The world's top trends, once a day. No spam, one-click unsubscribe.